US residents who have gastrointestinal issues sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will NOT utilize clinical sites.
Participants who meet the eligibility criteria are randomized into any of the three arms including: the control arm, VIOME's condition-based supplements (VCS) arm or the VIOME Precision Nutrition Program (VPNP) arm. Placebo, Viome-designed condition-based supplements and Viome's Precision Nutrition Program include supplements, may include dietary recommendations towards improving the symptoms associated with gastrointestinal wellness. The trial will last approximately 4 months for each participant.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
150
Precision supplement based on the participants microbiome sample results. Participants in this arm may have any combination of supplements, diet recommendations, and/or coaching.
Pre-formulated supplements based on overall health conditions. Participants in this arm may have any combination of supplements, diet recommendations, and/or coaching.
Viome Life Sciences
Bothell, Washington, United States
RECRUITINGEfficacy of VIOME's designed condition based supplements (VCS)
Number of participants that show an improvement in GI health compared to baseline survey assessment.
Time frame: ~4 months
Efficacy of VIOME Precision Nutrition Program (VPNP)
Number of participants that show an improvement in GI health compared to baseline survey assessment.
Time frame: ~4months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.